Does UPADACITINIB Cause Intestinal obstruction? 281 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 281 reports of Intestinal obstruction have been filed in association with UPADACITINIB (Rinvoq). This represents 0.4% of all adverse event reports for UPADACITINIB.
281
Reports of Intestinal obstruction with UPADACITINIB
0.4%
of all UPADACITINIB reports
1
Deaths
175
Hospitalizations
How Dangerous Is Intestinal obstruction From UPADACITINIB?
Of the 281 reports, 1 (0.4%) resulted in death, 175 (62.3%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Intestinal obstruction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 281 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Intestinal obstruction?
ADALIMUMAB (5,727)
VEDOLIZUMAB (1,263)
SEMAGLUTIDE (924)
INFLIXIMAB (907)
RISANKIZUMAB-RZAA (853)
BEVACIZUMAB (686)
LENALIDOMIDE (504)
CLOZAPINE (484)
OCTREOTIDE (463)
USTEKINUMAB (459)
Which UPADACITINIB Alternatives Have Lower Intestinal obstruction Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL